Eudaimonia Partners’s Delcath Systems DCTH Stock Holding History

Eudaimonia Partners’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	–	–	583
2021 Q1	$0	Buy	+3	New	+$55	﹤0.01%	1632

Other funds holding DCTH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eudaimonia Partners's DCTH Position: Q2 2021 in Review

Eudaimonia Partners sold out of Delcath Systems (DCTH) in Q2 2021, closing a stake of 3 shares.

Eudaimonia Partners first reported a position in DCTH in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 29 funds tracked by Wall St. Rank hold DCTH as of Q2 2021.

Eudaimonia Partners reported no remaining Delcath Systems position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 3 Delcath Systems shares in Q2 2021.
Eudaimonia Partners first reported a position in Delcath Systems in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Delcath Systems position peaked at $0 in Q1 2021.
29 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.